Maheshwari Anshul, the Chief Operating and Financial Officer at SI-BONE, Inc., recently sold 3,247 shares of the company's common stock. This transaction occurred on November 4, 2026, and is significant as it showcases the ongoing activity of executives in the surgical and medical instruments sector.

SI-BONE, Inc. is a company focused on developing innovative solutions for patients with musculoskeletal disorders. The company operates under the Standard Industrial Classification of Surgical & Medical Instruments & Apparatus. The recent filing indicates that the sale was executed as part of a 10b5-1 trading plan established on December 17, 2025.

The SEC filing, accession number 0001853089-26-000014, details that the shares were sold at a price of $25.00 each. Following this transaction, Anshul retains ownership of 211,250 shares, which includes 160,823 shares that are issuable upon the settlement of restricted stock units.

This sale may influence perceptions of executive confidence in the company, as well as highlight the importance of transparency in the surgical and medical instruments industry. Stakeholders often scrutinize such transactions to gauge the health and direction of the company.

Looking ahead, it remains to be seen if there will be further disclosures related to Anshul's holdings or additional transactions. The filing does not specify what will happen next.